{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T06:48:12Z","timestamp":1769755692914,"version":"3.49.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.jpba.2022.115061","type":"journal-article","created":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T21:55:17Z","timestamp":1663624517000},"page":"115061","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Analysis of impurity profiling of arbekacin sulfate by ion-pair liquid chromatography coupled with pulsed electrochemical detection and online ion suppressor-ion trap-time off light mass spectrometry"],"prefix":"10.1016","volume":"221","author":[{"given":"Zhouzhou","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyue","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Geng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erwin","family":"Adams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daijie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaozuo","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2022.115061_bib1","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.jmii.2020.08.018","article-title":"In vitro activity of arbekacin against multidrug-resistant gram-negative bacilli","volume":"54","author":"Albano","year":"2021","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"10.1016\/j.jpba.2022.115061_bib2","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1007\/s12161-014-0067-5","article-title":"Methodology studies on detection of aminoglycoside residues","volume":"8","author":"Tian","year":"2015","journal-title":"Food Anal. Methods."},{"key":"10.1016\/j.jpba.2022.115061_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.173922","article-title":"SARS-CoV-2 entry inhibitors by dual targeting TMPRSS2 and ACE2: an in silico drug repurposing study","volume":"896","author":"Baby","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jpba.2022.115061_bib4","doi-asserted-by":"crossref","first-page":"6351","DOI":"10.1016\/j.bmcl.2006.09.007","article-title":"Synthesis and antibacterial activity of novel neamine derivatives","volume":"24","author":"Minowa","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jpba.2022.115061_bib5","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.micres.2009.11.002","article-title":"Functional characterization of KanP, a methyltransferase from the kanamycin biosynthetic gene cluster of Streptomyces kanamyceticus","volume":"165","author":"Nepal","year":"2010","journal-title":"Microbiol. Res."},{"key":"10.1016\/j.jpba.2022.115061_bib6","unstructured":"Food and Drug Administration (USA), Center for Drug Evaluation and Research (CDER), Guidance for Industry: Good ANDA Submission Practices, January,2022. https:\/\/guidance.zoom.gov\/drugs\/guidance-compliance-regulatory-information\/guidance S-drugs."},{"key":"10.1016\/j.jpba.2022.115061_bib7","unstructured":"National Medical Products Administration (China), Center for Drug Evaluation (CDE), Technical requirements for quality and efficacy consistency evaluation of generic drugs for chemical injections, May, 2020. https:\/\/www.cde.org.cn\/main\/news\/viewInfoCommon\/d9c6f118b773f54e8feba3519bf78a11."},{"key":"10.1016\/j.jpba.2022.115061_bib8","unstructured":"European Medicines Agency (EU), Committee for Medicinal Products for Human Use (CHMP)\/Committee for Medicinal Products for Veterinary Use (CVMP), Guideline on setting specifications for related impurities inantibiotics, June, 2012. https:\/\/www.ema.europa.eu\/en\/setting-specifications-related-impurities-antibiotics."},{"key":"10.1016\/j.jpba.2022.115061_bib9","first-page":"352","article-title":"An isolated method and assignment for critical impurities in semi-synthetic process of arbekacin sulfate","volume":"74","author":"Chen","year":"2019","journal-title":"Pharmazie."},{"key":"10.1016\/j.jpba.2022.115061_bib10","first-page":"439","article-title":"Society of Japanese Pharmacopoeia","author":"The Japanese Pharmacopoeia 17th edition","year":"2016","journal-title":"YakujiNippo, Ltd., Tokyo."},{"key":"10.1016\/j.jpba.2022.115061_bib11","first-page":"93","article-title":"Society of Korean pharmacopoeia","author":"The Korean Pharmacopoeia 10th edition","year":"2016","journal-title":"Monogr., Part I, Seoul."},{"key":"10.1016\/j.jpba.2022.115061_bib12","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.cca.2013.01.004","article-title":"Rapid quantification of the aminoglycoside arbekacin in serum using high performance liquid chromatography\u2013tandem mass spectrometry","volume":"418","author":"Breaud","year":"2013","journal-title":"Clin. Chim. Acta."},{"key":"10.1016\/j.jpba.2022.115061_bib13","first-page":"1244","article-title":"Progress on quality control of aminoglycosides antibiotics","volume":"44","author":"Yuan","year":"2019","journal-title":"Chin. J. Antibio."},{"key":"10.1016\/j.jpba.2022.115061_bib14","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.chroma.2013.04.059","article-title":"Analysis of micronomicin by liquid chromatography with pulsed electrochemical detection","volume":"1295","author":"Yuan","year":"2013","journal-title":"J. Chromatogr. A."},{"key":"10.1016\/j.jpba.2022.115061_bib15","article-title":"Recent applications of the Charged Aerosol Detector for liquid chromatography in drug quality control","volume":"2020","author":"Schilling","year":"1619","journal-title":"J. Chromatogr. A."},{"key":"10.1016\/j.jpba.2022.115061_bib16","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.chroma.2015.07.045","article-title":"Aerosol-based detectors for liquid chromatography","volume":"1421","author":"Magnusson","year":"2015","journal-title":"J. Chromatogr. A."},{"key":"10.1016\/j.jpba.2022.115061_bib17","doi-asserted-by":"crossref","first-page":"7691","DOI":"10.1007\/s00216-015-8933-6","article-title":"Aquino, Fast determination of underivatized gentamicin C components and impurities by LC-MS using a porous graphitic carbon stationary phase","volume":"407","author":"Rodriquez","year":"2015","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jpba.2022.115061_bib18","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jpba.2010.02.032","article-title":"Comparative study on the analytical performance of different detectors for the liquid chromatographic analysis of tobramycin","volume":"53","author":"Chopra","year":"2010","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2022.115061_bib19","first-page":"1813","article-title":"European directorate for the quality of medicines & healthcare, council of Europe","author":"The European Pharmacopoeia 10th edition","year":"2020","journal-title":"Strasbourg."},{"key":"10.1016\/j.jpba.2022.115061_bib20","first-page":"3344","article-title":"European directorate for the quality of medicines & healthcare","author":"The European Pharmacopoeia 10th edition","year":"2020","journal-title":"Council of Europe, Strasbourg."},{"key":"10.1016\/j.jpba.2022.115061_bib21","first-page":"1598","article-title":"Chinese pharmacopoeia commission, national medical products administration","author":"The Chinese Pharmacopoeia 2020 edition","year":"2020","journal-title":"Beijing."},{"key":"10.1016\/j.jpba.2022.115061_bib22","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.aca.2016.05.039","article-title":"An integrated electrophoretic mobility control device with split design for signal improvement in liquid chromatography\u2013electrospray ionization mass spectrometry analysis of aminoglycosides using a heptafluorobutyric acid containing mobile phase","volume":"933","author":"Hung","year":"2016","journal-title":"Anal. Chim. Acta."},{"key":"10.1016\/j.jpba.2022.115061_bib23","first-page":"1428","article-title":"Rapid characterization of the related substances in netilmicin sulfate sample by HPLC-ESI-IT-MSn, Chin","volume":"45","author":"Yuan","year":"2010","journal-title":"Pharm. J."},{"key":"10.1016\/j.jpba.2022.115061_bib24","first-page":"1790","article-title":"Identification of the related substances in etimicin sulfate detected under the condition of Chinese Pharmacopoeia 2010 by LC \/MSn with propionic acid enhanced electrospray ionization","volume":"50","author":"Yuan","year":"2015","journal-title":"Chin. Pharm. J."},{"key":"10.1016\/j.jpba.2022.115061_bib25","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jpba.2017.07.063","article-title":"Separation and characterization of allergic polymerized impurities in cephalosporins by 2D-HPSEC\u00d7LC-IT-TOF MS","volume":"145","author":"Xu","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2022.115061_bib26","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.aca.2020.05.058","article-title":"Analysis of glyphosate, AMPA, Glufosinate and MPPA with ion chromatography tandem mass spectrometry using a membrane suppressor in the ammonium form application to surface water of low to moderate salinity","volume":"1133","author":"Geerdink","year":"2020","journal-title":"Anal. Chim. Acta."},{"key":"10.1016\/j.jpba.2022.115061_bib27","article-title":"Determination of xylooligosaccharides produced from enzymatic hydrolysis of beechwood xylan using high-performance anion-exchange chromatography tandem mass spectrometry","volume":"2022","author":"Rodr\u00edguez","year":"1666","journal-title":"J. Chromatogr. A."},{"key":"10.1016\/j.jpba.2022.115061_bib28","first-page":"422","article-title":"A bipolar membrane-based cation electrolytic membrane suppressor for ion chromatography","volume":"2019","author":"Zhao","year":"1603","journal-title":"J. Chromatogr. A."},{"key":"10.1016\/j.jpba.2022.115061_bib29","unstructured":"Eluent suppressors for ion chromatography, Thermo Scientific. http:\/\/www.cromlab.es\/Articulos\/Columnas\/HPLC\/Thermo\/Dionex\/Supresoras\/4270-DS-Eluent-Suppressors-23Nov10-LPN1290\u201310.pdf."},{"key":"10.1016\/j.jpba.2022.115061_bib30","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.chroma.2005.08.004","article-title":"Rational method development strategies on a fluorinated liquid chromatography stationary phase: Mobile phase ion concentration and temperature effects on the separation of ephedrine alkaloids","volume":"1095","author":"Bell","year":"2005","journal-title":"J. Chromatogr. A."},{"key":"10.1016\/j.jpba.2022.115061_bib31","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jpba.2007.10.034","article-title":"Determination of ephedrine alkaloids in Ephedra natural products using HPLC on a pentafluorophenylpropyl stationary phase","volume":"48","author":"Pellati","year":"2008","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2022.115061_bib32","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.chroma.2005.01.086","article-title":"Comparative study on the analytical performance of three waveforms for the determination of several aminoglycoside antibiotics with high performance liquid chromatography using amperometric detection","volume":"1085","author":"Cai","year":"2005","journal-title":"J. Chromatogr. A."},{"key":"10.1016\/j.jpba.2022.115061_bib33","unstructured":"The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), ICH Harmonized Tripartite Guideline Q2 (R1): Validation of Analytical Procedures: Text and Methodology, November, 2005. https:\/\/database.ich.org\/sites\/default\/files\/Q2%28R1%29%20Guideline.pdf."},{"key":"10.1016\/j.jpba.2022.115061_bib34","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/ja.2015.6","article-title":"Synthesis and antibacterial activity of 1-N-[(S)-\u03c9-amino-2-hydroxyalkyl] derivatives of dibekacin, 5-deoxydibekacin, 3\u2032-deoxykanamycin A and gentamicin B","volume":"68","author":"E.Umemura","year":"2015","journal-title":"J. Antibiot."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708522004824?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708522004824?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:26:44Z","timestamp":1760002004000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708522004824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":34,"alternative-id":["S0731708522004824"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2022.115061","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of impurity profiling of arbekacin sulfate by ion-pair liquid chromatography coupled with pulsed electrochemical detection and online ion suppressor-ion trap-time off light mass spectrometry","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2022.115061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115061"}}